Výsledky vyhledávání - "Irene C. Romera"

Akademický článek

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Autor: Stephen J. Nicholls, Santiago Tofé, Carel W. le Roux, David A. D’Alessio, Russell J. Wiese, Imre Pavo, Katelyn Brown, Govinda J. Weerakkody, Meltem Zeytinoglu, Irene C. Romera

Publikováno v: Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-15 (2024)

Abstract Background Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once weekly tirzepatide is app

Externí odkaz: https://doaj.org/article/fe7b1924c64f4aba90d45911656869ae

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.

Autor: Nicholls, Stephen J.¹ (AUTHOR), Tofé, Santiago² (AUTHOR), le Roux, Carel W.^3,4 (AUTHOR), D'Alessio, David A.⁵ (AUTHOR), Wiese, Russell J.⁶ (AUTHOR), Pavo, Imre⁷ (AUTHOR), Brown, Katelyn⁶ (AUTHOR), Weerakkody, Govinda J.⁶ (AUTHOR), Zeytinoglu, Meltem⁶ (AUTHOR), Romera, Irene C.⁸ (AUTHOR) romera_irene@lilly.com

Publikováno v: Cardiovascular Diabetology. 2/10/2024, Vol. 23 Issue 1, p1-15. 15p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Periodical

Findings from Eli Lilly and Company Broaden Understanding of Type 2 Diabetes (Reduction of Prevalence of Patients Meeting the Criteria for Metabolic Syndrome With Tirzepatide: a Post Hoc Analysis From the Surpass Clinical Trial Program).

Publikováno v: Diabetes Week; 3/11/2024, p282-282, 1p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání